Flaxseed (ALA) · Plant Omega-3 Source
Evidence-based review · Last updated 2026-05-24 · Educational reference, not medical advice. Consult a qualified clinician before changing supplement use, especially during pregnancy, hormone therapy, or anticoagulant treatment.
Quick Summary
Flaxseed (Linum usitatissimum) is the richest whole-food source of alpha-linolenic acid (ALA), a short-chain plant omega-3 fatty acid. One tablespoon of milled flaxseed delivers roughly 2.4 g of ALA, comfortably above the U.S. National Academies' Adequate Intake of 1.1 g/day for women and 1.6 g/day for men. Flaxseed also supplies the highest dietary density of lignans (SDG) of any common food, plus ~3 g of mixed soluble and insoluble fiber per tablespoon.
Higher ALA intake is associated with a ~14% lower risk of total cardiovascular disease in pooled cohort and trial data (Pan 2012). Milled flaxseed lowers blood pressure and modestly reduces LDL-cholesterol in randomized trials. Lignans show weak estrogen-modulating activity with mixed evidence in menopause and hormone-sensitive cancers.
⚠️ Critical limit: ALA does not replace EPA and DHA. Whole-body conversion of ALA to DHA is typically under 5% (and often under 0.1% in men). For outcomes that depend on long-chain omega-3 — cardiovascular event prevention at REDUCE-IT scale, mood support, pregnancy and infant brain/retinal development, dry eye disease, rheumatoid joint pain — flaxseed alone is not sufficient. Vegans and vegetarians who need EPA/DHA should pair flaxseed with algal oil.
What Is Flaxseed and Which Form Should You Choose?
Botanical and nutritional basics
Flaxseed (also called linseed) is the seed of Linum usitatissimum, cultivated for roughly 8,000 years across Mesopotamia, ancient Egypt, and the Indian subcontinent. Two main commercial varieties exist: traditional brown flax (richer in lignans) and golden flax (Solin variants, slightly lower ALA, slightly higher linoleic acid). Nutritionally they are nearly interchangeable.
Per 100 g of whole seed, flaxseed provides approximately:
| Component | Amount | Notes |
|---|---|---|
| Energy | ~534 kcal | Energy-dense |
| Total fat | ~42 g | ~22 g ALA, ~6 g LA, ~7.5 g MUFA, ~3.7 g SFA |
| ALA | ~22 g | Highest density among common whole foods |
| Protein | ~18 g | Contains all 8 essential amino acids |
| Total fiber | ~27 g | ~9 g soluble (mucilage) + ~18 g insoluble |
| Lignans (SDG) | 75–800 mg | 75–800× sesame seed; richest dietary source |
| Minerals | Mg, P, Cu, Mn, Se | 1 oz covers ~25% daily Mg, ~15% daily P |
| Vitamins | B1, B6, folate, γ-tocopherol | γ-tocopherol predominates (vs. α- in fish oil) |
Four common forms — only two are practical for ALA delivery
| Form | ALA bioavailability | Lignans | Fiber | Stability | Best use |
|---|---|---|---|---|---|
| Whole seed | Poor — the hard seed coat resists chewing; many seeds pass through intact | ✅ Retained | ✅ Retained | ✅ Stable in coat | Not recommended as an ALA source; modest fiber bonus only |
| Ground / milled | Best — once the coat is broken, ALA, lignans, and fiber all become bioavailable | ✅ Retained | ✅ Retained | ⚠️ Use within 24 h fresh-ground or refrigerate ≤2 weeks; ALA and lignans oxidize and turn bitter | First-choice form: stir into oats, yogurt, smoothies, baking |
| Cold-pressed flaxseed oil | Best — concentrated ALA (~55% of oil by weight) | ❌ None (lignans stay in the seed cake) | ❌ None | ⚠️ Highly oxidation-prone: dark bottle, refrigerated, used within ~6 weeks of opening, never heated | Cold dressings, drizzles, blended into yogurt or smoothies |
| Softgel capsules | Reliable, label-dosed (typically 500–1000 mg ALA per softgel) | ❌ None | ❌ None | ✅ Sealed, vitamin-E stabilized, shelf-stable | Travel, standardized dose, when ground seed is impractical |
Common mistakes to avoid
- Eating whole seeds expecting an ALA dose — the hard coat means most pass through undigested.
- Storing flaxseed oil at room temperature in a clear bottle — accelerated oxidation creates rancid aldehydes and lipid peroxides that may do net harm.
- Cooking with flaxseed oil — ALA is a highly unsaturated fat that degrades rapidly with heat; flax oil is a cold-use oil only.
- Buying pre-ground flax meal and leaving it at room temperature — refrigerate immediately and finish within ~2 weeks.
⚠️ Reminder #1: ALA is not EPA/DHA. Even the best-handled milled flaxseed cannot substitute for long-chain marine omega-3 for indications that require EPA or DHA (see §4).
A concrete example — why no realistic dose of ALA delivers clinical DHA
To obtain the European Food Safety Authority's general adult DHA intake of 250 mg/day from flaxseed oil alone would require approximately 9 grams (about 1.5 teaspoons) of flaxseed oil per day, assuming a whole-body ALA-to-DHA conversion rate of less than 0.1% in adult men. This is mathematically and physiologically not a viable substitution path. At the more realistic <1% conversion rate in adult men, the requirement quickly exceeds practical food intake. The conversion bottleneck is biological, not dose-dependent — adding more flaxseed does not solve it.
Other Plant-Source ALA Foods — How Does Flaxseed Compare?
Flaxseed is one of several plant foods that contribute ALA to the diet. The horizontal view matters because no single plant source covers every nutritional role:
| Plant source | ALA (% of dry weight) | Distinctive value | Caveat |
|---|---|---|---|
| Flaxseed | ~22% | Highest ALA density in a common food + richest lignan source + high fiber + low cost / wide availability | Oxidation-prone; whole seed poorly absorbed |
| Chia seed | ~17% | Forms a hydrocolloid gel (modest whole-seed absorption even without grinding); rich in Ca, Mg, fiber | Higher unit price |
| Hemp seed (hulled) | ~9% | Excellent protein quality (~30%), favorable n-6:n-3 ratio (~3:1), contains GLA | Lower ALA density |
| Walnut | ~9% (ALA) | Easy food integration; polyphenols, magnesium; supportive cardiovascular trial signals | Lower ALA density; higher unit cost |
| Perilla oil | ~58% (oil) | Highest ALA concentration among edible oils; East Asian culinary tradition | Strong flavor; limited Western availability |
| Sacha inchi oil | ~45–53% (oil) | Near-ideal n-3:n-6 (~1.5:1); high γ-tocopherol | Restricted to food use in some jurisdictions (e.g., China); higher cost |
| Canola oil | ~9% (oil) | Inexpensive cooking oil; more heat-tolerant than flax oil | Lower ALA density; industrially refined |
| Soybean oil | ~7% (oil) | Bulk commodity | Very high LA contributes to skewed n-6:n-3 ratios |
Cluster takeaway: Flaxseed offers the highest ALA density and the only meaningful lignan load among these foods. But every plant source shares the same biochemical bottleneck — whole-body conversion of ALA to EPA, and especially to DHA, is low. The practical differences between plant ALA sources lie mostly in their broader food matrix (fiber, protein, polyphenols, minerals), not in any of them being a better route to long-chain omega-3.
Flaxseed-Specific Evidence
ALA and cardiovascular risk (independent of conversion)
A growing body of cohort and pooled-trial data suggests ALA exerts cardiovascular effects independent of conversion to EPA/DHA, likely via direct anti-arrhythmic and lipid-modulating mechanisms:
- Pan et al. 2012 (PMID 23076616) — Systematic review and meta-analysis of 27 studies (cohort + RCT). Higher ALA intake was associated with a 14% lower risk of total cardiovascular disease (HR 0.86, 95% CI 0.77–0.97) versus low intake.
- Albert et al. 2005 (PMID 16301356) — Prospective analysis of 76,763 women in the Nurses' Health Study over 18 years. Higher ALA intake was associated with 38–40% lower risk of sudden cardiac death (top vs. bottom quintile). Other fatal CHD and non-fatal MI outcomes were not significant — the signal concentrates on arrhythmic death.
- Mozaffarian et al. 2005 (Circulation 111:157) — Health Professionals Follow-up Study (men). In participants with low long-chain n-3 intake, every additional 1 g/day of ALA was associated with roughly 58% lower CHD event risk, suggesting ALA may matter most when EPA/DHA intake is low.
Flaxseed and blood pressure
- Ursoniu et al. 2016 (PMID 26071633) — Meta-analysis of 11 RCTs (n=993). Flaxseed reduced SBP by ~2.85 mmHg and DBP by ~2.39 mmHg, with the strongest effects from whole or milled seed rather than oil alone.
- FLAX-PAD trial · Rodriguez-Leyva 2013 (PMID 24126178) — Double-blind RCT in 110 patients with peripheral arterial disease (75% with hypertension). 30 g/day of milled flaxseed for 6 months produced SBP −10 mmHg and DBP −7 mmHg vs. placebo. Effect size in this single trial is unusually large and warrants replication.
- Mechanism · Caligiuri 2014 (PMID 24777981) — FLAX-PAD sub-analysis: ALA appears to inhibit soluble epoxide hydrolase, raising circulating vasoactive oxylipins.
Flaxseed and blood lipids
- Pan et al. 2009 (PMC3361740) — Meta-analysis of 28 RCTs (n=1,539). Flaxseed reduced total cholesterol by ~0.10 mmol/L and LDL-C by ~0.08 mmol/L on average. Whole/milled seed outperformed isolated flax oil, consistent with combined contributions from ALA, soluble fiber, and lignans.
Comprehensive review
- Bassett, Rodriguez-Leyva, Pierce 2009 (PMID 19568181) — Narrative review of mechanistic and clinical cardiovascular evidence, including ALA's effects on lipids, blood pressure, inflammation, and arrhythmia.
Cluster takeaway — what flaxseed-specific evidence does and does not show
ALA delivers an independent cardiovascular signal that is real but observational and arrhythmia-leaning. Milled flaxseed has stronger short-term RCT signals for blood pressure and modest signals for LDL-C — both consistent with a useful adjunct in cardiometabolic care, but not equivalent to the prescription icosapent ethyl (REDUCE-IT) or large-trial outcome data for fish-oil-derived EPA/DHA. ⚠️ Reminder #2: ALA is not EPA/DHA. Flaxseed earns its place on the table for its food-matrix benefits, not by substituting for long-chain marine omega-3.
Lignans (SDG) and Estrogen-Sensitive Conditions
Flaxseed is the richest dietary source of secoisolariciresinol diglucoside (SDG), a precursor to enterodiol and enterolactone — mammalian lignans produced by gut bacteria (notably Bacteroides ovatus and Clostridium saccharogumia). Enterolactone binds estrogen receptors with low affinity and acts as a weak selective estrogen receptor modulator (SERM-like): mildly agonistic in low-estrogen environments (post-menopause) and partially antagonistic against endogenous estrogen in reproductive-age women.
Menopausal symptoms. Mixed RCT data. Some small trials in perimenopausal women report reductions in hot-flash frequency with 10 g/day of milled flaxseed; the larger NCCTG N08C7 Phase III RCT found no benefit of 7.5 g/day flaxseed vs. placebo for hot flashes. Flaxseed is not a first-line treatment for menopausal symptoms.
Breast cancer — supportive preclinical and observational signals, limited human RCT outcome data. Cell-line and animal work suggests SDG and enterolactone inhibit proliferation in ER+ breast cancer models. Observational cohorts in post-menopausal women link higher serum enterolactone with lower breast cancer incidence. Short-window pre-surgical RCTs (e.g., 25 g/day flaxseed for ~32 days in newly diagnosed ER+ breast cancer) report reduced Ki-67 proliferation markers and increased apoptosis in tumor tissue. However, no large RCT shows reduced breast cancer incidence or recurrence as a clinical endpoint. Major oncology bodies (ASCO, NCI) neither endorse nor contraindicate flaxseed in breast cancer survivors. Patients on endocrine therapy (tamoxifen, aromatase inhibitors) should consult their oncology team before high-dose use because of theoretical ER interactions.
Practical interpretation: Flaxseed lignans are a genuine point of difference from fish or algal oil, but human RCT evidence for hormone-related clinical outcomes is emerging, not established. Avoid framing flaxseed as a treatment for breast cancer or menopause.
Dietary Fiber, Cholesterol, Glycemia, and Gut Health
Flaxseed's ~27 g/100 g fiber load (roughly one-third soluble mucilage, two-thirds insoluble) is the second pillar of its whole-food value:
- LDL-C reduction — soluble mucilage binds bile acids, prompting hepatic compensation that consumes cholesterol. The Pan 2009 lipid meta-analysis finding that whole/milled flaxseed outperforms flax oil is most easily explained by combined effects of soluble fiber, lignans, and ALA.
- Postprandial glycemia — mucilage forms a viscous gel that slows gastric emptying and glucose absorption. Small RCTs in type 2 diabetes (e.g., 5 g/day soluble flax fiber for 3 months) report modest HbA1c improvements.
- Bowel regularity — insoluble fiber adds stool bulk and supports more regular bowel movements; useful for functional constipation.
- Gut microbiome — flax fiber plus lignans support growth of Bifidobacterium, Lactobacillus, and Bacteroides genera and increase short-chain fatty acid (notably butyrate) production.
- Satiety — the fiber-plus-protein-plus-ALA combination contributes to satiety; some trials show modest reductions in body weight and waist circumference at sustained intakes.
Starting tip: Begin at ~1 tablespoon (~10 g) of milled flaxseed per day and increase gradually to 2–3 tablespoons. Drink ample water — high fiber without sufficient fluids can produce the opposite of the intended bowel effect. Sudden large doses commonly cause bloating or gas.
Vegan and Vegetarian Best Practice — Combine Flaxseed with Algal DHA
The single most important practical message for plant-based readers:
| Goal | Practical approach | Source category |
|---|---|---|
| Baseline ALA intake (essential fatty acid + general cardiometabolic) | 1–2 tablespoons milled flaxseed per day (≈ 2.5–5 g ALA), plus dietary variety from chia, hemp, walnut | Flaxseed, chia, walnut |
| Direct EPA + DHA (bypassing the conversion bottleneck) | 200–500 mg/day algal EPA+DHA (DHA-led); pregnancy and lactation typically aim for ≥200 mg DHA daily | Algal oil (Schizochytrium sp.) |
| Menopause or hormone-sensitive cancer history (lignan considerations) | Individualized clinician advice; modest food-dose flaxseed + algal oil. Avoid high-dose flax during endocrine therapy unless approved | Both |
Why not flaxseed alone? Adult men, post-menopausal women, pregnant and lactating women, and infants all rely on direct DHA for membrane and neurological function. Whole-body ALA → DHA conversion of typically <5% (often <0.1% in men) cannot supply the DHA load these life stages require, even with generous flaxseed intake.
⚠️ Reminder #3: ALA is not EPA/DHA. A common answer-box question: "Can vegans get enough omega-3 from flaxseed alone?" The honest answer is no — flaxseed provides ALA, but human conversion to DHA is too low to cover most clinical needs. Plant-based readers should combine plant-source ALA (flaxseed, chia, walnut) with direct algal-source DHA + EPA.
What Flaxseed Does NOT Do (Important Limits)
Flaxseed is a valuable food. It is also frequently mis-positioned online. To be clear, flaxseed alone is not a substitute for any of the following, all of which require long-chain EPA or DHA:
- High-dose cardiovascular event prevention at REDUCE-IT scale — see fish oil and omega-3 overview.
- Pregnancy and infant brain/retinal development — see algal oil for plant-source DHA.
- Major depressive disorder adjunctive evidence — primarily EPA-driven; not addressed by ALA.
- Rheumatoid arthritis joint symptom relief — EPA/DHA-driven evidence.
- Dry eye disease symptom relief — EPA/DHA-driven evidence.
- Disease cure of any kind. No omega-3 source — plant or marine — has been demonstrated to cure cardiovascular disease, cancer, depression, or any other condition. The honest framing is risk modification and symptom support, not cure.
⚠️ Reminder #4: ALA is not EPA/DHA. If your goal depends on long-chain marine omega-3, flaxseed is the wrong tool. Use algal oil for vegan/vegetarian EPA+DHA, fish oil for the largest evidence base, or consult the omega-3 hub for an EPA vs. DHA vs. ALA overview.
⚠️ Reminder #5: ALA is not EPA/DHA. Beyond food-form recommendations, the central practical implication is consistent across this page — plant-based readers who require EPA or DHA must combine flaxseed with algal oil rather than relying on flaxseed alone.
Dosage and Practical Use
- Adequate intake (NIH baseline ALA): 1.6 g/day for men, 1.1 g/day for women. One tablespoon of milled flaxseed (~10 g) supplies ~2.4 g of ALA, comfortably above the AI.
- Blood pressure / blood lipid RCT dose: 30 g/day of milled flaxseed for 12+ weeks (the FLAX-PAD and Pan 2009 ranges). Start lower and build up.
- Pregnancy and lactation: Food-dose flaxseed (1–2 tbsp/day milled) is generally considered food-range. Avoid high-dose lignan supplementation or large daily volumes of flaxseed oil softgels during pregnancy — long-term safety data at concentrated doses are limited, and direct algal DHA is the established pregnancy-appropriate omega-3 route. Discuss with an OB or midwife.
- Children: Food-dose milled flaxseed in the family diet is fine; high-dose supplementation is not indicated.
- Adequate Intake values are estimated dietary references, not Recommended Dietary Allowances; they describe typical adequate intake, not a hard requirement.
Safety, Interactions, and Storage
| Concern | Practical guidance |
|---|---|
| Bloating / gas / loose stools | Common during fiber ramp-up; usually settles within 2–4 weeks. Start low (1 tsp), build to 1–2 tbsp/day, drink water. |
| Allergy | Rare but documented IgE-mediated flaxseed allergy. Avoid if known sensitivity. |
| Anticoagulants / antiplatelets (warfarin, DOACs, aspirin, clopidogrel) | High-dose flaxseed (≥30 g/day) may modestly compound bleeding risk via mild antiplatelet effects from ALA and lignans. Clinically significant events are uncommon, but monitor INR and bleeding signs and discuss with your prescriber. |
| Blood-glucose-lowering medications | High-dose flaxseed may enhance glucose-lowering effects; people with diabetes should monitor blood sugar and adjust under medical supervision. |
| Blood-pressure medications | The FLAX-PAD signal (–10/–7 mmHg) is meaningful; expect possible additive BP lowering and monitor. |
| Endocrine therapy (tamoxifen, aromatase inhibitors) | Use caution with high-dose flaxseed and concentrated lignan supplements during endocrine therapy because of theoretical estrogen-receptor interactions. Consult the oncology team. |
| SHBG / androgens | High-dose flaxseed may modestly increase sex hormone binding globulin and reduce free testosterone — relevant for those tracking androgen status. |
| Pregnancy / lactation | Food-dose intakes are acceptable; high-dose lignan or oil softgel supplementation lacks safety data and should be avoided unless cleared by a clinician. Direct algal DHA is the established pregnancy omega-3 route. |
| Oxidation / rancidity | Rancid flaxseed oil contains lipid peroxides and aldehydes linked to oxidative stress and inflammation. Refrigerate, store in dark glass, use within ~6 weeks of opening, and discard at the first hint of a paint-like or bitter smell. Never cook with flaxseed oil. |
| Cyanogenic glycosides | Flaxseed contains trace cyanogenic glycosides (linustatin, neolinustatin). Ordinary culinary intake (≤50 g/day) does not pose a toxicity concern. Extreme intakes (>100 g/day raw seed) combined with iodine deficiency could theoretically affect thyroid function, but typical supplement doses are not a concern. |
| Whole-seed pitfall | Hard seed coat resists chewing; whole seeds often pass undigested. Grind, or buy pre-milled and refrigerate. |
Storage rules at a glance: whole seeds — cool, dry, airtight, up to a year; pre-milled meal — refrigerate immediately, finish within ~2 weeks; flax oil — refrigerate from purchase, dark glass, use within ~6 weeks of opening, never heat, discard if rancid without exception.
Sustainability and Sourcing
Flaxseed is an agronomic crop with no ocean-pollution burden and no wild-fishery pressure, making it the lowest environmental-footprint omega-3 source per gram of ALA. It is a global commodity and the most affordable and broadly accessible plant omega-3 source.
For everyday quality choices:
- Prefer cold-pressed, organic flaxseed oil in dark glass with a printed best-by date well in the future.
- Buy whole seed and grind at home (a coffee or spice grinder works) and finish within 24 hours; otherwise buy pre-milled and refrigerate immediately.
- Look for third-party quality certifications (e.g., USP Verified, NSF) on capsule products as a basic quality proxy.
Frequently Asked Questions
1. Can flaxseed replace fish oil?
No, not for indications that depend on EPA or DHA — including cardiovascular event prevention, mood support, anti-inflammatory effects in rheumatoid arthritis, dry eye, and pregnancy/infant neurodevelopment. Flaxseed provides ALA, and whole-body conversion to DHA is typically under 5%. Use fish oil or algal oil when EPA/DHA is the requirement.
2. How do vegans get enough omega-3?
Combine plant-source ALA (1–2 tablespoons milled flaxseed daily, plus chia, hemp, walnut for variety) with algal oil for direct EPA and DHA — typically 200–500 mg/day combined EPA+DHA. Flaxseed alone is not enough for adult men, post-menopausal women, pregnant and lactating women, or infants.
3. Flaxseed vs. chia — which is better?
Both deliver ALA. Flaxseed has higher ALA density (~22% vs. ~17%) and the richest lignan load of any common food. Chia has higher calcium and magnesium and forms a gel that improves whole-seed absorption without grinding. They are complementary rather than competitive — dietary variety wins.
4. Does flaxseed cause cancer?
The honest summary: an early 2004 meta-analysis raised a question about high ALA intake and prostate cancer, but later large prospective cohorts have not consistently replicated the signal. Current institutional consensus does not restrict dietary ALA, including flaxseed, in the general population. Men with personal or family history of prostate cancer considering high-dose ALA supplementation should discuss with their clinician. For breast cancer, preclinical and observational lignan data lean protective, but human RCT outcome data are limited; survivors on endocrine therapy should consult their oncology team before high-dose use.
5. Is flaxseed oil safe to cook with?
No. Flaxseed oil is rich in polyunsaturated ALA, which degrades rapidly with heat. Use it cold — drizzled on salads, blended into yogurt or smoothies — and store refrigerated in dark glass. Discard at the first hint of rancid or bitter flavor.
6. Whole seed or ground — does it matter?
Yes — substantially. Whole seeds are physically resistant to digestion and many pass through intact, delivering little ALA. Grind at home and use within 24 hours, or buy pre-milled meal and refrigerate immediately.
7. How much flaxseed per day?
One tablespoon of milled flaxseed (~10 g, ~2.4 g ALA) is enough to exceed adult Adequate Intake. Cardiovascular RCTs typically used 30 g/day (~3 tablespoons) over 12+ weeks. Start low to allow your gut to adapt to the fiber.
8. Do I need to take a lignan supplement?
No. Milled flaxseed already supplies SDG lignans in their natural matrix. Concentrated lignan extracts are an extra step with weaker safety data, particularly during endocrine therapy or pregnancy.
9. Will flaxseed lower my blood pressure?
Randomized trials suggest yes, modestly. A meta-analysis of 11 RCTs found average reductions of roughly –2.85 mmHg systolic and –2.39 mmHg diastolic; a single dedicated trial in patients with peripheral arterial disease reported larger effects (–10/–7 mmHg) over 6 months. Effects are stronger with whole or milled seed than with flax oil alone. Flaxseed is an adjunct to, not a replacement for, prescribed antihypertensive therapy.
Tags
Body Systems: Cardiovascular · Endocrine & Metabolic · Digestive & Gut · Immune System · Reproductive
Mechanisms: ALA direct antiarrhythmic action · Soluble fiber bile acid sequestration · Lignan SERM-like weak estrogenic modulation · Soluble epoxide hydrolase (sEH) inhibition · SPM precursor (partial ALA→EPA conversion) · Short-chain fatty acids + gut microbiota modulation
Evidence Tier: Mixed evidence (medium-large RCT supported · long-term hard-outcome trials absent)
Dosage Range: 10-30 g/d milled flaxseed (AI 1.1-1.6 g/d ALA · BP/lipid RCT 30 g/d · 1 tbsp ≈ 2.4 g ALA)
Last Evidence Review: 2026-05-24 · Reviewed by Evidence Synthesis Lead + Regulatory Compliance Lead
Related Goals
Related Lifestyles
Related Ingredients
References
All PMIDs verified by upstream Scita evidence document (2026-05-24 · 8/8 PASS).
- PMID 23076616 · Pan A, Chen M, Chowdhury R, Wu JHY, Sun Q, Campos H, Mozaffarian D, Hu FB. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 2012;96(6):1262–73.
- PMID 16301356 · Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, Willett WC, Hu FB. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 2005;112(21):3232–8.
- Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, Rimm EB. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005;111(2):157–64.
- PMID 26071633 · Ursoniu S, Sahebkar A, Andrica F, Serban C, Banach M (Lipid and Blood Pressure Meta-analysis Collaboration). Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trials. Clin Nutr 2016;35(3):615–25.
- PMID 24126178 · Rodriguez-Leyva D, Weighell W, Edel AL, et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients (FLAX-PAD). Hypertension 2013;62(6):1081–9.
- PMID 24777981 · Caligiuri SPB, Edel AL, Aliani M, Pierce GN. Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an ALA-induced inhibition of soluble epoxide hydrolase. Hypertension 2014;64(1):53–9.
- PMC3361740 · Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 2009;90(2):288–97.
- PMID 19568181 · Bassett CMC, Rodriguez-Leyva D, Pierce GN. Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed. Appl Physiol Nutr Metab 2009;34(5):965–74.
- PMID 15051847 · Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr 2004;134(4):919–22.
- National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids — Fact Sheet for Health Professionals. ods.od.nih.gov
For the broader EPA-vs-DHA-vs-ALA framework and the full 18-PMID evidence base spanning all omega-3 sources, see the omega-3 cluster hub.
Related Pages
- Omega-3 (overview) — EPA, DHA, and ALA in one place; the full marine + plant evidence base.
- Algal oil — direct vegan/vegetarian DHA (and EPA), the recommended companion to flaxseed for plant-based readers.
- Fish oil — largest clinical evidence base for long-chain EPA/DHA, including cardiovascular outcomes.
- Krill oil — phospholipid-bound EPA/DHA with astaxanthin; an alternative marine form.
Educational Disclaimer
Educational reference only. Not medical advice. Consult a qualified clinician before changing supplement use — especially during pregnancy, lactation, anticoagulant therapy, endocrine therapy, or with a personal or family history of hormone-sensitive cancer.